LD-2 disclosure · 3rd Quarter - Report
LABORATORY ACCESS & BENEFITS (LAB) COALITION
Coverage · No income or expenses were reported on this filing.
Client
- Description
- Coaltion to drive the future of laboratory and diagnostic testing policies
- Location
- District of Columbia · United States of America
Registrant
- Description
- Health Care and Health Care Coverage
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
1 issueHealth Issues
Issues related to laboratory testing, reimbursement, access, benefits, and value. At-home testing. Issues relating to the Protecting Access to Medicare Act (PAMA) and the clinical laboratory fee schedule including the Telehealth Modernization Act (H.R. 7623). Regulation of laboratory-developed tests, including the FDAs final rule, Docket No. FDA-2023-N-2177. Issues relating to value-based arrangements for lab testing. Issues related to the use of artificial intelligence in health care.
LobbyistsBRETT MEEKS
Covered position (BRETT MEEKS): Former Deputy Health Policy Director for the Senate Committee on Health, Education, Labor and Pensions
TargetedSENATE · HOUSE OF REPRESENTATIVES